Baird analyst Andrew Wittmann downgrades Diversey Hldgs (NASDAQ:DSEY) from Outperform to Neutral and announces $8.5 price target.
Evelo Biosciences Announces Publication Of Scientific Basis For SINTAX Medicines In Frontiers In Immunology
Peer-reviewed article explains the immunology of the small intestinal axis
Company to hold a virtual Science Symposium on Wednesday, November 30, 2022, at 8:00am ET
CAMBRIDGE, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE)